IMC-Chicago, LLC
- SEC CIK
- 0001452861
- Latest filing
- Aug 6, 2026
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by IMC-Chicago, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings
- Shares (Q2 2026)
- 36,515
- Value
- $1.24M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 36,515 | $1.24M | <0.1% | −53,054−59.2% | Reduced | Holders |
| Q1 2026 | 89,569 | $2.70M | <0.1% | +89,569 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −92,126−100.0% | Sold out | Holders |
| Q2 2025 | 92,126 | $1.54M | <0.1% | +20,170+28.0% | Added | Holders |
| Q1 2025 | 71,956 | $1.11M | <0.1% | +71,956 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −33,328−100.0% | Sold out | Holders |
| Q3 2024 | 33,328 | $600.6K | <0.1% | −36,977−52.6% | Reduced | Holders |
| Q2 2024 | 70,305 | $1.14M | <0.1% | +45,157+179.6% | Added | Holders |
| Q1 2024 | 25,148 | $354.8K | <0.1% | +25,148 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −91,254−100.0% | Sold out | Holders |
| Q3 2023 | 91,254 | $930.8K | 0.1% | −41,676−31.4% | Reduced | Holders |
| Q2 2023 | 132,930 | $1.00M | <0.1% | −96,919−42.2% | Reduced | Holders |
| Q1 2023 | 229,849 | $2.03M | 0.3% | +125,574+120.4% | Added | Holders |
| Q4 2022 | 104,275 | $951.0K | 0.2% | +27,762+36.3% | Added | Holders |
| Q3 2022 | 76,513 | $617.0K | 0.1% | −110,485−59.1% | Reduced | Holders |
| Q2 2022 | 186,998 | $1.41M | 0.1% | +56,245+43.0% | Added | Holders |
| Q1 2022 | 130,753 | $1.23M | 0.1% | −110,134−45.7% | Reduced | Holders |
| Q4 2021 | 240,887 | $1.93M | 0.1% | +130,638+118.5% | Added | Holders |
| Q3 2021 | 110,249 | $1.07M | 0.1% | −21,428−16.3% | Reduced | Holders |
| Q2 2021 | 131,677 | $1.30M | 0.1% | +49,265+59.8% | Added | Holders |
| Q1 2021 | 82,412 | $951.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.